PDF) Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers
Por um escritor misterioso
Descrição
Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers
PDF) Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review
Efficacy and Safety of Pitavastatin in a Real-World Setting: Observational Study Evaluating SaFety in Patient Treated with Pitavastatin in Korea (PROOF Study)
Statin-related myotoxicity Endocrinología y Nutrición (English Edition)
Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations: Molecular Therapy
Impact of critical illness on cholesterol and fatty acids: insights into pathophysiology and therapeutic targets, Intensive Care Medicine Experimental
PDF] Statin myopathy: A common dilemma not reflected in clinical trials
Statins, fibrates, thiazolidinediones and resveratrol as adjunctive therapies in sepsis: could mitochondria be a common target?, Intensive Care Medicine Experimental
Atherogenic dyslipidemia in Latin America: prevalence, causes and treatment. Consensus
PDF) Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers
Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components. - Abstract - Europe PMC
Frontiers Autoantibodies in the pathogenesis of idiopathic inflammatory myopathies: Does the endoplasmic reticulum stress response have a role?
Risk Factors and Drug Interactions Predisposing to Statin-Induced Myopathy
Vitamins
Statin Toxicity Circulation Research
de
por adulto (o preço varia de acordo com o tamanho do grupo)
